corporate venture capital
-
Corporate venture capital-backed funding for digital health startups increased sharply in 2021
According to a CB Insight’s report, GV (formerly Google Ventures) funded the most digital health companies with 22 investments, making it most active investor in that sector for four years in a row.
-
Navigating the life science and healthcare funding landscape
Which capital funding options fit your healthcare or life science business?
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Exclusive: GE Ventures to be spun out of GE amidst massive restructuring
GE is in the midst of spinning off several companies to generate cash as it undergoes a huge restructuring. Sources say it will include GE Ventures, the corporate venture capital arm of GE, that invests in healthcare as well as nonhealthcare startups.
-
What percentage of investments by provider ventures are actually getting adopted?
You would be surprised to learn that a few health systems are reporting that they have high rate of adoption of technologies they have invested.
-
Rock Health: Record Q1 brings in $1.6B for digital health investments, disease diagnosis segment dominates (Updated)
That figure reflected investment across 77 digital health deals, dominated by disease diagnosis in terms of total investment and monitoring of disease in terms of deal volume.
-
Partners HealthCare raises $171M for second innovation fund for healthcare startups (Updated)
Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.
-
Insurance navigator Wellthie looks beyond healthcare with $5M Series A round
Aflac Corporate Ventures took part in the Series A round. Last month, the insurer announced plans to set up a $100 million fund to invest in early stage companies relevant to Aflac’s core business.
-
J&J corporate VC: The biggest rookie mistake that entrepreneurs make is…
Renee Ryan, vice president, venture investments at Johnson & Johnson’s corporate venture capital arm, talks about what’s exciting in healthcare, her favorite investments, and mistakes that entrepreneurs make.
-
Devices & Diagnostics, Startups
Medical device industry makes a comeback, poised to see first yearly funding increase since 2014
A new report projects that the global medical devices industry is poised to see its first funding increase since 2014, news that is likely to cheer startups and entrepreneurs in the field.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
5 must-read stories: Digital pathology startup Proscia’s fundraise, a corporate VC investment survey
Plus, an analysis of the Providence St Joseph Health merger and what the plans are for technology, patient safety and mental health and a look at some of the largest digital health investments outside the U.S.
-
Corporate venture capital can no longer be “dumb money”
Corporate venture capitalists are not only pumping more money to spur innovation, but they are going beyond traditional comfort zones.
-
Report: Corporate venture capital bullish on seed stage health investments
Corporate venture investment has emerged as an important alternative to more traditional healthcare funding avenues. However, there’s still a dearth of information about their activity.
-
McKesson, Blue Cross top digital health’s most trusted corporate VCs
Part II in our research examining which corporate venture capitalists you can trust and rely on.
-
Why the consumer-driven world of healthcare still has its limits
Stop thinking consumers will pay for your app and start thinking about how it goes viral.